The frequency and efficacy of genetic testing in individuals with scimitar syndrome.
The frequency and efficacy of genetic testing in individuals with scimitar syndrome.
复制标题
DOI:
10.1017/s1047951121002535
复制
发表时间:
2022-04
影响因子:
1
通讯作者:
Morris SA
中科院分区:
文献类型:
--
作者:
Fick TA;Scott DA;Lupo PJ;Weigand J;Morris SA
Scimitar syndrome (SS) is a rare congenital heart defect composed of partial anomalous pulmonary venous connection from the right lung, via a scimitar vein, to the inferior vena cava rather than the left atrium. Genetic conditions associated with SS have not been well-investigated at present. Our study included patients with SS diagnosed at Texas Children’s Hospital from January 1987 to July 2020. Medical records were evaluated to determine if genetic testing was performed, including chromosomal microarray analysis (CMA) or whole-exome sequencing (WES). Copy number variants (CNVs) identified as pathogenic/likely pathogenic and variants of unknown significance were collected. Analysis of cardiac and extracardiac findings were performed via chart review. Ninety-eight patients were identified with SS, 89 of which met inclusion criteria. A chromosome analysis or CMA was performed in 18 patients (20%). WES was performed in six patients following negative CMA testing. A molecular genetic diagnosis was made in 7 of 18 cases (39% of those tested). Ninety-six percent of the cohort had some type of extra-cardiac finding, with 43% having asthma and 20% having a gastrointestinal pathology. Of the seven patients with positive genetic testing, all had extra-cardiac anomalies with all but one having gastrointestinal findings and 30% having congenital diaphragmatic hernia. Genetic testing revealed an underlying diagnosis in roughly 40% of those tested. Given the relatively high prevalence of pathogenic variants, we recommend CMA and WES for patients with SS and extra-cardiac defects.
影响因子:
3.7
作者:
Nash D;Arrington CB;Kennedy BJ;Yandell M;Wu W;Zhang W;Ware S;Jorde LB;Gruber PJ;Yost HJ;Bowles NE;Bleyl SB
通讯作者:
Bleyl SB